Hamps Bio Ltd.

Financial

	Hamps Bio	Mono Pharmacare	Chandra Bhagat Pharm
Operational Metrics
Financials
5 yr Average ROE	17.75 %	6.96 %	2.7 %
5yr average Equity Multiplier	2.66	3.78	2.82
5yr Average Asset Turnover Ratio	1.39	0.97	1.54
5yr Avg Net Profit Margin	5.48 %	2.29 %	0.58 %
Price to Book	0.0	0.0	0.0
P/E	38.82	17.62	29.58
5yr Avg Cash Conversion Cycle	10.22 Days	164.46 Days	56.06 Days
Inventory Days	38.15 Days	276.94 Days	127.31 Days
Days Receivable	49.29 Days	79.75 Days	39.27 Days
Days Payable	79.37 Days	65.03 Days	45.24 Days
5yr Average Interest Coverage Ratio	3.3	2.12	1.54
5yr Avg ROCE	22.28 %	9.76 %	10.71 %
5yr Avg Operating Profit Margin	15.08 %	5.42 %	2.17 %
5 yr average Debt to Equity	1.2	2.25	0.85
5yr CAGR Net Profit	33.03 %	28.37 %	37.62 %
5yr Average Return on Assets	7.45 %	2.06 %	0.95 %
Shareholdings
Promoter Holding	71.99 %	56.72 %	71.2 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.78 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Hamps Bio	Mono Pharmacare	Chandra Bhagat Pharm
Product Wise Break-Up	Product Wise Break-Up Freeze Drying Products 50.4 Medicine Products 49.6 0	Product Wise Break-Up Medicine Products 0 0 Freeze Drying Products 0 Others 100	Product Wise Break-Up Medicine Products 0 API`s 100.0 Freeze Drying Products 0
Product Wise Break-Up	Product Wise Break-Up Freeze Drying Products 50.4 Medicine Products 49.6 0	Product Wise Break-Up Medicine Products 0 0 Freeze Drying Products 0 Others 100	Product Wise Break-Up Medicine Products 0 API`s 100.0 Freeze Drying Products 0
Location Wise Break-Up	Location Wise Break-Up India 86.58 USA 5.02 UAE 3.2 Canada 2.63 Australia 0.33 Africa 0.17 Europe 0.01 Others 2.06	-	Location Wise Break-Up Canada 0 Australia 0 Africa 0 India 10.68 USA 0 UAE 0 Europe 0 Others 89.32
Operating Profit Break-Up	Operating Profit Break-Up Freeze Drying Products 50.4 Medicine Products 49.6	-	-